Cargando…
MicroRNAs in tear fluids predict underlying molecular changes associated with Alzheimer’s disease
Extracellular circulating microRNAs (miRNAs) have been discussed as potential biomarkers for Alzheimer’s disease (AD) diagnosis. As the retina is a part of the CNS, we hypothesize that miRNAs expression levels in the brain, particularly neocortex–hippocampus, eye tissues, and tear fluids are similar...
Autores principales: | Wijesinghe, Printha, Xi, Jeanne, Cui, Jing, Campbell, Matthew, Pham, Wellington, Matsubara, Joanne A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Life Science Alliance LLC
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027899/ https://www.ncbi.nlm.nih.gov/pubmed/36941055 http://dx.doi.org/10.26508/lsa.202201757 |
Ejemplares similares
-
Ergothioneine, a dietary antioxidant improves amyloid beta clearance in the neuroretina of a mouse model of Alzheimer’s disease
por: Wijesinghe, Printha, et al.
Publicado: (2023) -
Proteins and microRNAs are differentially expressed in tear fluid from patients with Alzheimer’s disease
por: Kenny, Aidan, et al.
Publicado: (2019) -
The Expression Levels of MicroRNAs Differentially Expressed in Sudden Sensorineural Hearing Loss Patients’ Serum Are Unchanged for up to 12 Months after Hearing Loss Onset
por: Abgoon, Reyhaneh, et al.
Publicado: (2023) -
MicroRNA Signature and Cellular Characterization of Undifferentiated and Differentiated House Ear Institute-Organ of Corti 1 (HEI-OC1) Cells
por: Wijesinghe, Printha, et al.
Publicado: (2022) -
Cerebrospinal fluid microRNAs as potential biomarkers in Alzheimer’s disease
por: Noor Eddin, Ahmed, et al.
Publicado: (2023)